Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven V Manoukian, MD
SCRI Development Innovations, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Osceola Regional Medical Center
Kissimmee, Florida, United States
- Northside Hospital
St. Petersburg, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- North Georgia Heart Center
Gainesville, Georgia, United States
- Redmond Regional Medical Center
Rome, Georgia, United States
- Archbold Medical Center
Thomasville, Georgia, United States
- Lenox Hill Hospital
New York, New York, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Doylestown Hospital
Doylestown, Pennsylvania, United States
- Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
- Centennial Heart
Nashville, Tennessee, United States
- Chippenham Hospital
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 31 Dec 2018
- Completion
- 31 Mar 2019
- Last update posted
- 13 May 2021
- Registered enrollment
- 535
- Registry id
- NCT01522417
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.